KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Invested Capital: 2009-2025

Historic Invested Capital for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $2.0 billion.

  • Idexx Laboratories' Invested Capital rose 7.93% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 7.93%. This contributed to the annual value of $2.2 billion for FY2024, which is 1.39% up from last year.
  • Idexx Laboratories' Invested Capital amounted to $2.0 billion in Q3 2025, which was down 1.06% from $2.0 billion recorded in Q2 2025.
  • Idexx Laboratories' 5-year Invested Capital high stood at $2.2 billion for Q4 2024, and its period low was $828.4 million during Q1 2021.
  • In the last 3 years, Idexx Laboratories' Invested Capital had a median value of $1.8 billion in 2024 and averaged $1.8 billion.
  • In the last 5 years, Idexx Laboratories' Invested Capital surged by 121.07% in 2021 and then fell by 10.53% in 2022.
  • Quarterly analysis of 5 years shows Idexx Laboratories' Invested Capital stood at $1.5 billion in 2021, then declined by 10.53% to $1.4 billion in 2022, then surged by 58.34% to $2.2 billion in 2023, then increased by 1.39% to $2.2 billion in 2024, then grew by 7.93% to $2.0 billion in 2025.
  • Its last three reported values are $2.0 billion in Q3 2025, $2.0 billion for Q2 2025, and $1.8 billion during Q1 2025.